New drug combo aims to tame acromegaly hormone levels
NCT ID NCT07037420
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether adding ALXN2420 (a growth hormone blocker) to standard acromegaly treatment can lower IGF-1 levels more than placebo. About 60 adults with acromegaly who are already on a stable dose of somatostatin analogs will receive either ALXN2420 or placebo injections for 15 weeks. The main goal is to see if the drug reduces IGF-1 levels, a key marker of disease control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ALXN2420 (a growth hormone blocker)
What this could lead to
If it works, this could offer a new treatment option for people with acromegaly whose disease is not fully controlled by current therapy.
What could go wrong
This is an early phase 2 trial with only 60 participants, so results may not apply to everyone. The drug may not lower hormone levels enough or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGLos Angeles, California, 90048, United States
-
Research Site
RECRUITINGLos Angeles, California, 90095, United States
-
Research Site
RECRUITINGTorrance, California, 90502, United States
-
Research Site
WITHDRAWNAurora, Colorado, 80045, United States
-
Research Site
RECRUITINGBoston, Massachusetts, 02114, United States
-
Research Site
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
Research Site
RECRUITINGLas Vegas, Nevada, 89148, United States
-
Research Site
RECRUITINGNew York, New York, 10032, United States
-
Research Site
RECRUITINGPortland, Oregon, 97239, United States
-
Research Site
RECRUITINGCABA, C1012AAR, Argentina
-
Research Site
RECRUITINGCiudad de Buenos Aires, C1180AAD, Argentina
-
Research Site
RECRUITINGCiudad de Buenos Aires, C1199, Argentina
-
Research Site
RECRUITINGCiudad de Buenos Aires, C1405DCS, Argentina
-
Research Site
RECRUITINGCuritiba, 80030-110, Brazil
-
Research Site
RECRUITINGRibeirão Preto, 14049-901, Brazil
-
Research Site
RECRUITINGRio de Janeiro, 20231-092, Brazil
-
Research Site
RECRUITINGSão Paulo, 01420-000, Brazil
-
Research Site
NOT_YET_RECRUITINGBeijing, 100730, China
-
Research Site
NOT_YET_RECRUITINGGuangzhou, 510120, China
-
Research Site
NOT_YET_RECRUITINGKunming, 650032, China
-
Research Site
NOT_YET_RECRUITINGShanghai, 201107, China
-
Research Site
RECRUITINGCopenhagen, 2100, Denmark
-
Research Site
RECRUITINGOdense, 5464, Denmark
-
Research Site
RECRUITINGBudapest, 1083, Hungary
-
Research Site
RECRUITINGBudapest, 1134, Hungary
-
Research Site
RECRUITINGPécs, 7624, Hungary
-
Research Site
RECRUITINGSzeged, 6725, Hungary
-
Research Site
RECRUITINGCona, 44124, Italy
-
Research Site
RECRUITINGGenoa, 16132, Italy
-
Research Site
RECRUITINGMessina, 98125, Italy
-
Research Site
NOT_YET_RECRUITINGMilan, 20132, Italy
-
Research Site
NOT_YET_RECRUITINGNaples, 80131, Italy
-
Research Site
RECRUITINGPisa, 56126, Italy
-
Research Site
RECRUITINGRoma, 00168, Italy
-
Research Site
RECRUITINGKaunas, LT50009, Lithuania
-
Research Site
RECRUITINGVilnius, 09112, Lithuania
-
Research Site
NOT_YET_RECRUITINGLeiden, 2333 ZA, Netherlands
-
Research Site
RECRUITINGRotterdam, 3015 CE, Netherlands
-
Research Site
WITHDRAWNBydgoszcz, 85-605, Poland
-
Research Site
NOT_YET_RECRUITINGGliwice, 44-102, Poland
-
Research Site
NOT_YET_RECRUITINGKrakow, 31-501, Poland
-
Research Site
RECRUITINGWarsaw, 03-242, Poland
-
Research Site
RECRUITINGWroclaw, 50-367, Poland
-
Research Site
RECRUITINGBucharest, 011863, Romania
-
Research Site
NOT_YET_RECRUITINGCluj-Napoca, 400006, Romania